Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Case Report
DOI: 10.1055/s-0040-1705648
Submitted: 02-14-2022
Published: 02-14-2022

Consenso da Associação Brasileira de Nutrologia sobre manejo da dislipidemia secundária à obesidade infanto-juvenil

Universidade de Ribeirão Preto, ABRAN, Brasil
Universidade Federal do Rio Grande do Sul, ABRAN, Brasil
Universidade Federal do Rio Grande do Sul, Brasil
University of Cologne, Germany
Universidade Federal de São Carlos, Brasil
Faculdade de Medicina da Fundação Padre Albino / ABRAN - Brasil
Dislipidemia lipídeos aterosclerose crianças e adolescentes

Abstract

Objetivo: Estabelecer consenso sobre o manejo da dislipidemia secundária à obesidade infanto-juvenil. Métodos: Foi realizada pesquisa bibliográfica nas bases de dados Medline, Scielo e LILACS. Com base nas evidências científicas, o grupo de trabalho estabeleceu as condutas recomendadas pelo Departamento de Nutrologia Pediátrica da ABRAN. Resultados: Os autores redigiram o consenso que foi aprovado pela Diretoria da Associação Brasileira de Nutrologia - ABRAN. Conclusões: São apresentadas, com base nas evidências científicas, as recomendações para a condução dos casos de dislipidemia associados à obesidade na infância e adolescência.

Metrics

Metrics Loading ...

References

  1. Singh GK, Kogan MD, van Dyck PC. Changes in state-specific childhood obesity and overweight prevalence in the United States from 2003 to 2007. Arch Pediatr Adolesc Med. 2010;164(7):598-607.
  2. IBGE. Pesquisa de orçamentos familiares 2008-2009 - Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. IBGE. Instituto Brasileiro de Pesquisa Geográfica e Estatística. Ministério do Planejamento, Orçamento e Gestão; 2010.
  3. Lughetti L, Bruzzi P, Predieri B. Evaluation and management of hyperlipidemia in children and adolescents. Curr Opin Pediatr. 2010;22(4):485-93.
  4. de Mello ED, Nogueira-de-Almeida CA. Manejo da obesidade infanto-juvenil. International Journal of Nutrology. 2017;10(1):322-4.
  5. Nogueira-de-Almeida CA, Pires LA, dos Santos RG. Comparação de indicadores de perfis glicêmico e lipídico entre crianças e adolescentes obesos egressos de serviço público ou privado da cidade de Ribeirão Preto (SP). Medicina (Ribeirao Preto Online). 2016;49(6):504-10.
  6. Nogueira-de-Almeida CA, Mello ED. Obesidade. In: Nogueira-de-Almeida CA, Mello ED, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  7. Mello ED, Nogueira-de-Almeida CA, Mello PP, Mello PD. Dislipidemia. In: Nogueira-de-Almeida C, Mello E, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  8. Giuliano IdCB, Coutinho MSSdA, Freitas SFTd, Pires MMdS, Zunino JN, Ribeiro RQdC. Lípides séricos em crianças e adolescentes de Florianópolis, SC: Estudo Floripa saudável 2040. Arquivos Brasileiros de Cardiologia. 2005;85:85-91.
  9. Moura EC, Castro CMd, Mellin AS, Figueiredo DBd. Perfil lipídico em escolares de Campinas, SP, Brasil. Revista de Saúde Pública. 2000;34:499-505.
  10. Ribeiro RQC. Epidemiologia das dislipidemias em escolares. Belo Horizonte: UFMG; 2000.
  11. Faria ECd, Dalpino FB, Takata R. Lípides e lipoproteínas séricos em crianças e adolescentes ambulatoriais de um hospital universitário público. Revista Paulista de Pediatria. 2008;26:54-8.
  12. Nogueira-de-Almeida CA, Mello ED. Por que um livro de Nutrologia Pediátrica? In: Nogueira-de-Almeida CA, Mello ED, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  13. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31(6):1235-9.
  14. Lawlor DA, Davey Smith G, Ebrahim S. Birth weight is inversely associated with coronary heart disease in post-menopausal women: findings from the British women’s heart and health study. Journal of epidemiology and community health. 2004;58(2):120-5.
  15. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16(11):1348-60.
  16. Dietz WH. Breastfeeding may help prevent childhood overweight. Jama. 2001;285(19):2506-7.
  17. Roberts SB. Prevention of hypertension in adulthood by breastfeeding? Lancet. 2001;357(9254):406-7.
  18. Brotons C, Ribera A, Perich RM, Abrodos D, Magana P, Pablo S, et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis. 1998;139(1):1-9.
  19. Nogueira-de-Almeida CA, Garcia J, Caixe SH, Benedeti ACGS. Ultrasonographic Assessment of the Common Carotid Intima-Media Complex in Normal Weight Children and in Overweight/Obese Children. The FASEB Journal. 2016;30(1 Supplement):1165.3.
  20. Francoso LA, Coates V. Anatomicopathological evidence of the beginning of atherosclerosis in infancy and adolescence. Arq Bras Cardiol. 2002;78(1):131-42.
  21. Costa KCM, Lima JC, Almeida CANd, Ciampo LAD, Souza CSBd. Variation of the brachial artery diameter in obese children: present and future. Revista Paulista de Pediatria. 2012;30(3):431-7.
  22. Nogueira-de-Almeida CA, Garcia J, Caixe SH, Benedeti AC. Ultrasonographic Assessment of the Common Carotid Intima-Media Complex in Normal Weight Children and in Overweight/Obese Children. The FASEB Journal. 2016;30(1 Supplement):1165.3-.3.
  23. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol. 2007;27(5):1159-65.
  24. Pinho AP, Brunetti IL, Pepato MT, Almeida CANd. Metabolic syndrome in overweight/obese female adolescents. Revista Paulista de Pediatria. 2012;30(1):51-6.
  25. Pilz S, Horejsi R, Moller R, Almer G, Scharnagl H, Stojakovic T, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. The Journal of clinical endocrinology and metabolism. 2005;90(8):4792-6.
  26. Ballesteros MN, Cabrera RM, Saucedo Mdel S, Aggarwal D, Shachter NS, Fernandez ML. High intake of saturated fat and early occurrence of specific biomarkers may explain the prevalence of chronic disease in northern Mexico. The Journal of nutrition. 2005;135(1):70-3.
  27. Frontini MG, Srinivasan SR, Xu J, Tang R, Bond MG, Berenson GS. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study. Pediatrics. 2008;121(5):924-9.
  28. McGill HC, Jr., McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 2008;117(9):1216-27.
  29. Tracy RE, Newman WP, 3rd, Wattigney WA, Berenson GS. Risk factors and atherosclerosis in youth autopsy findings of the Bogalusa Heart Study. Am J Med Sci. 1995;310 Suppl 1:S37-41.
  30. Berenson GS, Srinivasan SR, Bao W, Newman WP, 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. The New England journal of medicine. 1998;338(23):1650-6.
  31. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88(2):119-24.
  32. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. The New England journal of medicine. 2005;352(16):1685-95.
  33. Schulpis K, Karikas GA. Serum Cholesterol and Triglyceride Distribution in 7767’a0School-aged Greek Children. 1998;101(5).
  34. Bao W, Srinivasan SR, Wattigney WA, Bao W, Berenson GS. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study. Arch Intern Med. 1996;156(12):1315-20.
  35. Botham KM, Mayers PA. Sintese, transporte e excreção do colesterol. In: Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA, editors. Bioquímica Ilustrada de Harper. Porto Alegre: AMGH; 2017. p. 267-79.
  36. Xavier HT, Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose. Arq Bras Cardiol. 2013;101(4):22.
  37. SBP. Obesidade na infância e adolescência - Manual de Orientação. São Paulo; 2012.
  38. National Cholesterol Education Program (NCEP): Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3):495-501.
  39. Daniels SR, Greer FR, Committee on N. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198-208.
  40. I Diretriz de Prevenção da Aterosclerose na Infância e na Adolescência. Arquivos Brasileiros de Cardiologia. 2005;85:3-36.
  41. Consenso Brasileiro para a Normatização da Determinação Laboratorial do Perfil Lipídico, (2017).
  42. Pereira A, Gagliardi A, Lottenberg A, Chacra A, Faludi A, Sposito A, et al. I Diretriz Brasileira de Hipercolesterolemia Familiar (HF). Arquivos Brasileiros de Cardiologia. 2012;99:1-28.
  43. Non LR, Escota GV, Powderly WG. HIV and its relationship to insulin resistance and lipid abnormalities. Transl Res. 2017;183:41-56.
  44. [Consensus on management of dyslipidemia in pediatrics]. Archivos argentinos de pediatria. 2015;113(2):177-86.
  45. S BY, L. CBM, C. BL, I. HBM. Diagnóstico y tratamiento de las dislipidemias en niños y adolescentes: Recomendaciones de la Rama de Nutrición de la Sociedad Chilena de Pediatría. Revista chilena de pediatría. 2014;85:367-77.
  46. Yoon JM. Dyslipidemia in Children and Adolescents: When and How to Diagnose and Treat? Pediatric Gastroenterology, Hepatology & Nutrition. 2014;17(2):85-92.
  47. Girardet JP, Luc G, Rieu D, Bruckert E, Darmaun D, Farnier M. Prise en charge des hypercholestérolé mies de l’enfant: recommandations du Comité de nutrition de la Société française de pédiatrie et de la Nouvelle société française d’athérosclérose. Archives de Pédiatrie. 2011;18:12.
  48. Mata P, Alonso R, Ruiz A, Gonzalez-Juanatey JR, Badimón L, Díaz-Díaz JL, et al. Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso. Atención Primaria. 2015;47(1):56-65.
  49. Caramelli B, Giuliana ICB. Dislipidemia em crianças e adolescentes. Rev Soc Cardiol Estado de São Paulo. 2005;6:6.
  50. Holmes KW, Kwiterovich PO, Jr. Treatment of dyslipidemia in children and adolescents. Curr Cardiol Rep. 2005;7(6):445-56.
  51. Kavey R-EW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood. Circulation. 2003;107(11):1562-6.
  52. Zappalla FR, Gidding SS. Lipid management in children. Endocrinol Metab Clin North Am. 2009;38(1):171-83.
  53. Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newburger JW. Niacin treatment of hypercholesterolemia in children. Pediatrics. 1993;92(1):78-82.
  54. Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. Cochrane Database Syst Rev. 2014(6):CD001918.
  55. Engler MM, Engler MB, Malloy MJ, Paul SM, Kulkarni KR, Mietus-Snyder ML. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol. 2005;95(7):869-71.
  56. Kennedy MJ, Jellerson KD, Snow MZ, Zacchetti ML. Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents. Paediatr Drugs. 2013;15(5):335-42.
  57. Achimastos A, Alexandrides T, Alexopoulos D, Athyros V, Bargiota A, Bilianou E, et al. Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Hormones (Athens, Greece). 2016;15(1):8-14.
  58. Kersting M, Alexy U, Clausen K. Using the concept of Food Based Dietary Guidelines to Develop an Optimized Mixed Diet (OMD) for German children and adolescents. Journal of pediatric gastroenterology and nutrition. 2005;40(3):301-8.
  59. Lughetti L, Predieri B, Balli F, Calandra S. Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review. Journal of endocrinological investigation. 2007;30(8):700-19.
  60. Olson RE. Is it wise to restrict fat in the diets of children? Journal of the American Dietetic Association. 2000;100(1):28-32.
  61. Mohammed A, Mohammed T. Mercury, arsenic, cadmium and lead in two commercial shark species (Sphyrna lewini and Caraharinus porosus) in Trinidad and Tobago. Marine pollution bulletin. 2017;119(2):214-8.
  62. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114(1):82-96.
  63. Kris-Etherton PM, Griel AE, Psota TL, Gebauer SK, Zhang J, Etherton TD. Dietary stearic acid and risk of cardiovascular disease: intake, sources, digestion, and absorption. Lipids. 2005;40(12):1193-200.
  64. Santos RD, Gagliardi ACM, Xavier HT, Magnoni CD, Cassani R, Lottenberg AMP, et al. I Diretriz sobre o consumo de gorduras e saúde cardiovascular. Arquivos Brasileiros de Cardiologia. 2013;100:1-40.
  65. Mello PP, Mello ED, Nogueira-de-Almeida CA. Constipação Intestinal. In: Nogueira-de-Almeida C, Mello E, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  66. Santos ZEA. Necessidades Nutricionais de Crianças e Adolescentes Saudáveis. In: Nogueira-de-Almeida C, Mello E, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  67. Jakulj L, Vissers MN, Rodenburg J, Wiegman A, Trip MD, Kastelein JJP. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels. The Journal of Pediatrics.148(4):495-500.
  68. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486-97.
  69. Boreham C, Twisk J, Murray L, Savage M, Strain JJ, Cran G. Fitness, fatness, and coronary heart disease risk in adolescents: the Northern Ireland Young Hearts Project. Med Sci Sports Exerc. 2001;33(2):270-4.
  70. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948-67.
  71. Tonstad S. Role of lipid-lowering pharmacotherapy in children. Paediatr Drugs. 2000;2(1):11-22.
  72. Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106(1):143-60.
  73. Xydakis AM, Guyton JR, Chiou P, Stein JL, Jones PH, Ballantyne CM. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. Am J Cardiol. 2004;94(6):795-7.
  74. Arambepola C, Farmer AJ, Perera R, Neil HA. Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. Atherosclerosis. 2007;195(2):339-47.
  75. O’Gorman CS, Higgins MF, O’Neill MB. Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatric cardiology. 2009;30(4):482-9.
  76. Van der Graaf A, Kastelein JJ, Wiegman A. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention. J Inherit Metab Dis. 2009;32(6):699-705.
  77. Nogueira-de-Almeida CA, Mello ED. Como Fazer um Plano Alimentar. In: Nogueira-de-Almeida CA, Mello ED, editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed. São Paulo: Manole; 2016.
  78. Anderson JW. Plant Fiber in Foods. 2 ed: HCF Nutrition Research Foundation; 1990.
  79. Silva GLd. Fontes dietéticas de fitoesteróis e seu efeito na saúde humana. 2016.

How to Cite

Nogueira-de-Almeida, C. A., Mello, E. D. de, Mello, P. P. de, Mello, P. D. de, Zorzo, R. A., & Ribas Filho, D. (2022). Consenso da Associação Brasileira de Nutrologia sobre manejo da dislipidemia secundária à obesidade infanto-juvenil. International Journal of Nutrology, 10(4), 161–178. https://doi.org/10.1055/s-0040-1705648